Ask HN: 个性化 mRNA 癌症疫苗，目前的研发进展有多真实？
2 分•作者: imnotlost•5 个月前
我发现了这个用于设计个性化 mRNA 癌症疫苗的开源工作流程：
<p>https://philfung.github.io/openvaxx/</p>
以及最近关于一位与研究人员合作，为他的狗开发个性化癌症疫苗的男子的报道：
<p>https://medicalxpress.com/news/2026-03-ai-cancer-vaccine-dog-oncologist.html</p>
这让我开始思考，目前人类个性化 mRNA 药物的技术、研究和初创企业领域是什么样的。<p>
有没有 HN 社区的人在这个领域工作，或者与此领域相关？我特别感兴趣的是：
- 如今，在大型机构之外，该流程的实际情况如何
- 哪些环节变得更便宜或更容易获得
- 流程的哪些部分正在被软件，以及可能的新 AI 模型接管
- 真正的瓶颈在哪里：测序、靶点选择、生产、质量控制、监管，还是其他方面
- 是否有人正在围绕更个性化的 mRNA 疗法构建工具、基础设施或初创企业
查看原文
I came across this open-source workflow for designing personalized mRNA cancer vaccines:<p>https://philfung.github.io/openvaxx/<p>And this recent story about a man who worked with researchers to create a personalized cancer vaccine for his dog:<p>https://medicalxpress.com/news/2026-03-ai-cancer-vaccine-dog-oncologist.html<p>It got me wondering what the current technology, research, and startup landscape looks like for personalized mRNA medicine in humans.<p>Are any HN people working in this space, or close to it? I’m especially curious about:
- how real the pipeline is today outside major institutions
- which parts are getting cheaper or more accessible
- which parts of the pipeline is being taken over by software and possibly new AI models
- where the real bottlenecks are: sequencing, target selection, manufacturing, QC, regulation, or something else
- whether anyone is building tools, infrastructure, or startups around more individualized mRNA therapies